The promise and peril of knowledge translation for food allergy prevention

doi:10.1016/j.anai.2023.08.598

. 2023 Nov;131(5):544-546.

doi: 10.1016/j.anai.2023.08.598. Epub 2023 Aug 29.

The promise and peril of knowledge translation for food allergy prevention

Marcus S Shaker¹, Elissa M Abrams², Douglas P Mack³, Edmond S Chan⁴, Edward G A Iglesia⁵, David B K Golden⁶, Matthew Greenhawt⁷

Affiliations

¹ Dartmouth Geisel School of Medicine, Hanover, New Hampshire; Section of Allergy and Immunology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire. Electronic address: Marcus.shaker@dartmouth.edu.
² Section of Allergy and Clinical Immunology, Department of Pediatrics, University of Manitoba, Winnipeg, Manitoba, Canada.
³ Department of Pediatrics, McMaster University, Hamilton, Canada.
⁴ Division of Allergy, Department of Pediatrics, The University of British Columbia, BC Children's Hospital, Vancouver, British Columbia, Canada.
⁵ Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
⁶ School of Medicine, Johns Hopkins University, Baltimore, Maryland.
⁷ Section of Allergy and Clinical Immunology, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colorado.

PMID: 37652233
PMCID: PMC10964205
DOI: 10.1016/j.anai.2023.08.598

The promise and peril of knowledge translation for food allergy prevention

Marcus S Shaker et al. Ann Allergy Asthma Immunol. 2023 Nov.

. 2023 Nov;131(5):544-546.

doi: 10.1016/j.anai.2023.08.598. Epub 2023 Aug 29.

Authors

Marcus S Shaker¹, Elissa M Abrams², Douglas P Mack³, Edmond S Chan⁴, Edward G A Iglesia⁵, David B K Golden⁶, Matthew Greenhawt⁷

Affiliations

¹ Dartmouth Geisel School of Medicine, Hanover, New Hampshire; Section of Allergy and Immunology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire. Electronic address: Marcus.shaker@dartmouth.edu.
² Section of Allergy and Clinical Immunology, Department of Pediatrics, University of Manitoba, Winnipeg, Manitoba, Canada.
³ Department of Pediatrics, McMaster University, Hamilton, Canada.
⁴ Division of Allergy, Department of Pediatrics, The University of British Columbia, BC Children's Hospital, Vancouver, British Columbia, Canada.
⁵ Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
⁶ School of Medicine, Johns Hopkins University, Baltimore, Maryland.
⁷ Section of Allergy and Clinical Immunology, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colorado.

PMID: 37652233
PMCID: PMC10964205
DOI: 10.1016/j.anai.2023.08.598

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest:

MS: MS: is a member of the Joint Task Force on Practice Parameters, serves on the editorial board of The Journal of Allergy and Clinical Immunology In Practice, is an associate editor of Annals of Allergy, Asthma, and Immunology, serves on the board of directors of the American Academy of Allergy, Asthma, and Immunology and has participated in research that has received funding from DBV. Views expressed are his own.

EA: is an employee of Public Health Agency of Canada (PHAC); views expressed are her own and not those of PHAC

DM: DM has provided consultation for Alladapt and consultation speaker services for Bausch Health, ALK-Abello, Medexus, Miravo, and is an investigator for DBV, ALK-Abello, Astra-Zeneca, Dermavant and serves on the editorial board of the Journal of Food Allergy

EC: has received research support from DBV Technologies; has been a member of advisory boards for Pfizer, Miravo, Medexus, Leo Pharma, Kaleo, DBV, AllerGenis, Sanofi Genzyme, Bausch Health, Avir Pharma, AstraZeneca, ALK; is co-lead of CPS/CSACI Food Allergy Prevention Position Statements; is on the Executive of the CSACI (Canadian Society of Allergy and Clinical Immunology); and is on the Executive of the CPS (Canadian Paediatric Society) Allergy Section.

EI: supported by NIH AHRQ 5K12HS026395-04.

DBKG is a consultant for Novartis, Aquestive, Kokua, ThermoFisher; receives clinical trial support from Novartis, Genentech, Aimmune, Allergy Therapeutics, GSK, Merck, Pfizer, Regeneron, AstraZeneca, Sanofi; and receives royalties from UpToDate.

MG: is a consultant for Aquestive; is a member of physician/medical advisory boards for DBV Technologies, Nutricia, Novartis, Acquestive, Allergy Therapeutics, AstraZeneca, ALK-Abello, and Prota; is an unpaid member of the scientific advisory council for the National Peanut Board and medical advisory board of the International Food Protein Induced Enterocolitis Syndrome Association; is a member of the Brighton Collaboration Criteria Vaccine Anaphylaxis 2.0 working group; is the senior associate editor for the Annals of Allergy, Asthma, and Immunology, and is member of the Joint Taskforce on Allergy Practice Parameters. He has received honorarium for lectures from ImSci and multiple state/local allergy societies.

References

1. Fleischer DM, Chan ES, Venter C, Spergel JM, Abrams EM, Stukus D, et al. A Consensus Approach to the Primary Prevention of Food Allergy Through Nutrition: Guidance from the American Academy of Allergy, Asthma, and Immunology; American College of Allergy, Asthma, and Immunology; and the Canadian Society for Allergy and Clinical Immunology. J Allergy Clin Immunol Pract. 2021;9(1):22–43 e4. - PubMed
1. Fleischer DM, Sicherer S, Greenhawt M, Campbell D, Chan E, Muraro A, et al. Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants. J Allergy Clin Immunol. 2015;136(2):258–61. - PubMed
1. Togias A, Cooper SF, Acebal ML, Assa’ad A, Baker JR, Jr., Beck LA, et al. Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases-sponsored expert panel. J Allergy Clin Immunol. 2017;139(1):29–44. - PMC - PubMed
1. Shaker M, Abrams EM, Greenhawt M. Clinician Adoption of US Peanut Introduction Guidelines-A Case for Conditional Recommendations and Contextual Considerations to Empower Shared Decision-Making. JAMA Netw Open. 2020;3(7):e2011535. - PubMed
1. Soriano VX, Peters RL, Ponsonby AL, Dharmage SC, Perrett KP, Field MJ, et al. Earlier ingestion of peanut after changes to infant feeding guidelines: The EarlyNuts study. J Allergy Clin Immunol. 2019;144(5):1327–35 e5. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

K12 HS026395/HS/AHRQ HHS/United States

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

[1] Fleischer DM, Chan ES, Venter C, Spergel JM, Abrams EM, Stukus D, et al. A Consensus Approach to the Primary Prevention of Food Allergy Through Nutrition: Guidance from the American Academy of Allergy, Asthma, and Immunology; American College of Allergy, Asthma, and Immunology; and the Canadian Society for Allergy and Clinical Immunology. J Allergy Clin Immunol Pract. 2021;9(1):22–43 e4. - PubMed

[2] Fleischer DM, Chan ES, Venter C, Spergel JM, Abrams EM, Stukus D, et al. A Consensus Approach to the Primary Prevention of Food Allergy Through Nutrition: Guidance from the American Academy of Allergy, Asthma, and Immunology; American College of Allergy, Asthma, and Immunology; and the Canadian Society for Allergy and Clinical Immunology. J Allergy Clin Immunol Pract. 2021;9(1):22–43 e4. - PubMed

[3] Fleischer DM, Sicherer S, Greenhawt M, Campbell D, Chan E, Muraro A, et al. Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants. J Allergy Clin Immunol. 2015;136(2):258–61. - PubMed

[4] Fleischer DM, Sicherer S, Greenhawt M, Campbell D, Chan E, Muraro A, et al. Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants. J Allergy Clin Immunol. 2015;136(2):258–61. - PubMed

[5] Togias A, Cooper SF, Acebal ML, Assa’ad A, Baker JR, Jr., Beck LA, et al. Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases-sponsored expert panel. J Allergy Clin Immunol. 2017;139(1):29–44. - PMC - PubMed

[6] Togias A, Cooper SF, Acebal ML, Assa’ad A, Baker JR, Jr., Beck LA, et al. Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases-sponsored expert panel. J Allergy Clin Immunol. 2017;139(1):29–44. - PMC - PubMed

[7] Shaker M, Abrams EM, Greenhawt M. Clinician Adoption of US Peanut Introduction Guidelines-A Case for Conditional Recommendations and Contextual Considerations to Empower Shared Decision-Making. JAMA Netw Open. 2020;3(7):e2011535. - PubMed

[8] Shaker M, Abrams EM, Greenhawt M. Clinician Adoption of US Peanut Introduction Guidelines-A Case for Conditional Recommendations and Contextual Considerations to Empower Shared Decision-Making. JAMA Netw Open. 2020;3(7):e2011535. - PubMed

[9] Soriano VX, Peters RL, Ponsonby AL, Dharmage SC, Perrett KP, Field MJ, et al. Earlier ingestion of peanut after changes to infant feeding guidelines: The EarlyNuts study. J Allergy Clin Immunol. 2019;144(5):1327–35 e5. - PubMed

[10] Soriano VX, Peters RL, Ponsonby AL, Dharmage SC, Perrett KP, Field MJ, et al. Earlier ingestion of peanut after changes to infant feeding guidelines: The EarlyNuts study. J Allergy Clin Immunol. 2019;144(5):1327–35 e5. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The promise and peril of knowledge translation for food allergy prevention

Affiliations

The promise and peril of knowledge translation for food allergy prevention

Authors

Affiliations

Conflict of interest statement

Similar articles

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical